30-day average of 13 articles ยท scale โ100 to +100
Across 13 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Axon Enterprise news is Somewhat Bullish (+34)
on a scale from โ100 to +100.
That is up 16 points from the previous 30 days (+18).
๐ป Software revenue grew 43% YoY to $437M, nearing half of total revenue.
๐ Stock fell 18.2% after Q3 report and $1.0B convertible note offering.
Somewhat Bearish -45
Why Did Axon Stock Fall?
AI-generated analysis
Key insights
๐ Axon stock fell 18.2% on November 6, 2026, following the release of its fiscal Q3 2026 report and a $1.0 billion convertible note offering.
๐ฐ The company's balance sheet shifted from net cash to net debt, with total debt at $2,969 million versus $1,655 million in cash as of September 30, 2026.
๐ Management lowered its free cash flow guidance for 2026 to a range of $350-$400 million from a previous target of $450 million due to increased inventory investment.
๐ Axon is investing $1.2 billion in Skydio, a drone maker, using a combination of cash and stock as part of its strategic expansion.
๐ Revenue recognition for three federal Dedrone deployments totaling approximately $130 million has been moved out of fiscal 2026.
๐ป Software and Services revenue grew 43% year-over-year to $437 million in Q3, approaching half of the company's total revenue.
๐ Annual recurring revenue increased 40% to $1.8 billion, highlighting strong growth in the software segment.
๐ Operating margins were low at 2.0% over the trailing twelve months, significantly below the S&P 500 average of 19.0%.
๐ The stock trades at 96.3 times reported earnings and 7.3 times sales, reflecting a high valuation relative to current profitability.
โก Total revenue grew 33.6% year-over-year through September 2026, though TASER 7 sales declined modestly.
๐ Bullish signals
๐ปSoftware and Services revenue surged 43% year-over-year to $437 million in fiscal Q3 2026, approaching half of total revenue.
๐Annual recurring revenue grew 40% to $1.8 billion, demonstrating strong stickiness in the software business.
โกTotal revenue increased 33.6% year-over-year through September 2026, maintaining double-digit growth despite market headwinds.
๐The company maintains a high valuation multiple of 7.3 times sales and 96.3 times earnings, indicating strong investor confidence in future cash flows.
๐ Risk factors
๐Axon stock fell 49.9% between August and November 2026, with an 18.2% drop on the day of the Q3 report release.
๐Management lowered free cash flow guidance for 2026 to $350-$400 million from a prior target of $450 million.
๐ฐThe company's balance sheet flipped from net cash to net debt, with total debt at $2,969 million versus $1,655 million in cash.
๐Operating margins were weak at 2.0% over the trailing twelve months, compared to a 19.0% average for the S&P 500.
๐ Revenue recognition for approximately $130 million of federal Dedrone deployments was moved out of fiscal 2026.
โกTASER revenue declined modestly due to lower sales of the TASER 7 model.
Article
Axon Enterprise (AXON) shares experienced significant volatility, falling 49.9% between August and November 2026, with the steepest decline occurring after the release of its fiscal Q3 2026 report. The stock dropped 18.2% on November 6 following management's announcement that it would borrow $1.0 billion via convertible notes to fund strategic investments and inventory buildup. This capital raise marked a shift in the company's balance sheet, moving from a net cash position to one carrying more debt than cash.
Management revised its financial outlook for fiscal year 2026, guiding free cash flow between $350 million and $400 million, down from a prior target of $450 million. A substantial portion of the borrowed funds is allocated to a $1.2 billion investment in Skydio, a drone manufacturer, which will be paid for using a mix of cash and stock. Additionally, Axon adjusted its revenue recognition timing, moving drone revenue associated with three federal Dedrone deployments out of 2026, representing nearly 500 basis points of expected growth.
Despite the stock price decline, Axon's software business continues to expand rapidly, with Software and Services revenue rising 43% year-over-year to $437 million in Q3. However, the company faces valuation challenges, trading at 96.3 times reported earnings compared to 21.9 for the S&P 500, while operating margins remain low at 2.0% over the trailing twelve months versus 19.0% for the broader index.
Revenue growth remains robust overall, with total revenue increasing 33.6% year-over-year through September 2026, though TASER sales declined modestly due to lower demand for the TASER 7 model. Analysts and investors are closely watching the software segment's performance as a key indicator of future profitability, with fiscal Q4 2026 results expected in February 2027.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Axon Enterprise, Inc. (AXON) stock closed down 10.25% at $351.40, underperforming the broader market despite gains across major indices. The S&P 500 rose 0.62%, the Dow Jones Industrial Average increased by 0.58%, and the Nasdaq gained 0.83%. Over the past month, shares of the stun gun and body camera manufacturer have depreciated by 24.35%, a sharper decline than the Aerospace sector's loss of 5.4% and outpacing the S&P 500's overall gain of 0.8%. The stock faces upcoming earnings expectations that could influence investor sentiment, with analysts projecting earnings per share of $1.66 for the current quarter, representing a 17.73% increase from the prior-year period. Revenue is expected to reach $779.78 million, which would be up 29.18% year-over-year.
Full-year projections from Zacks Consensus Estimates indicate earnings of $8.12 per share and revenue of $3.57 billion, reflecting growth of +18.54% and +28.31%, respectively, compared to the prior year. Investors are advised to monitor recent analyst estimate revisions, as these often correlate with future stock price performance; Axon currently carries a Zacks Rank of #3, which translates to a Hold recommendation on the scale from #1 (Strong Buy) to #5 (Strong Sell). Although Zacks research notes that #1 ranked stocks have achieved an average annual return of +25% since 1988, the company's current valuation metrics suggest it trades at a premium relative to its industry peers. Specifically, the Forward P/E ratio stands at 48.24 versus an industry average of 37.19, and the PEG ratio is recorded at 1.45 compared to the Aerospace - Defense Equipment industry average of 2.53.
Additional analysis indicates that Axon operates within the Aerospace - Defense Equipment industry, which holds a Zacks Industry Rank of 149, placing it in the bottom 39% of over 250 industries tracked. Research suggests that industries ranked in the top 50% outperform the bottom half by a factor of 2 to 1, highlighting potential relative strength considerations for sector leaders versus those with lower rankings. The article emphasizes that tracking metrics such as estimate revisions and Zacks ranks can help investors identify actionable opportunities, referencing an external track record where the model has audited performance benefits. Read more about this analysis at Zacks Investment Research.
๐ Stock down 10.25% on negative sentiment despite S&P 500 gains.
๐น Analysts expect EPS $1.66 and revenue of $779.78M next quarter.
โ ๏ธ Zacks Rank #3 (Hold) with Forward P/E ratio above industry average.
๐ Axon Enterprise stock dropped 10.25% in the latest session, trading at $351.40 despite positive gains across the S&P 500 and Nasdaq.
๐ The company's shares have fallen 24.35% over the past month, significantly underperforming its Aerospace sector peers.
๐น Investors are eagerly awaiting Axon's upcoming earnings report, which is expected to show EPS of $1.66, a 17.73% increase year-over-year.
๐ Revenue forecasts for the next quarter stand at $779.78 million, representing a 29.18% growth from the prior-year period.
๐ Full-year consensus estimates project earnings of $8.12 per share and revenue of $3.57 billion, with significant year-over-year growth.
๐ Recent analyst estimate revisions remain unchanged over the last 30 days, keeping Axon Enterprise at a Zacks Rank of #3 (Hold).
๐ฐ The stock trades at a Forward P/E ratio of 48.24, which is above the industry average of 37.19 for the Aerospace - Defense Equipment sector.
๐ The PEG ratio stands at 1.45, compared to an industry average of 2.53, suggesting a different valuation growth outlook than peers.
๐ The company operates within an industry ranked #149 out of 250+ industries by Zacks Industry Rank, placing it in the bottom 39%.
๐ Historical data indicates that top-rated industries tend to outperform the bottom half by a factor of 2 to 1.
๐ Analysts suggest using the Zacks Rank system, which tracks estimate changes and has delivered an average annual return of +25% for #1 ranked stocks since 1988.
Bullish Signals
Monitor Zacks Rank #3 for upgrade opportunities.
Consensus EPS estimates stable for 30 days.
Risk Factors
Stock down 10.25% despite market gains, trading at $351.40.
Shares fell 24.35% last month, underperforming sector and index.
Forward P/E of 48.24 exceeds industry average of 37.19.
PEG ratio of 1.45 is lower than peer average of 2.53.
Zacks rank of #3 indicates Hold, below top-performing half.
Analyst ratings remain Hold despite historical Buy preference.
Bullish Signals
Investors can utilize Zacks Rank #3 (Hold) as a baseline to monitor for future upgrade opportunities that may indicate strong business outlook changes.
Zacks Consensus EPS estimates have remained unchanged over the last 30 days, providing stability in analyst expectations.
Risk Factors
Stock price dropped 10.25% to $351.40 despite positive gains across the broader market, including S&P 500 up 0.62%, Nasdaq up 0.83%, and Dow up 0.58%.
Shares depreciated by 24.35% over the past month, significantly underperforming both the Aerospace sector's loss of 5.4% and the S&P 500's gain of 0.8%.
Forward P/E ratio of 48.24 is notably higher than the industry average Forward P/E of 37.19, indicating a premium valuation that may not be fully justified by current performance.
Axon Enterprise trades at a PEG ratio of 1.45 compared to an industry average of 2.53 for Aerospace - Defense Equipment, which could suggest growth is priced in differently than peers.
The company sits on the bottom 39% of all industries according to its Zacks Industry Rank of 149 out of 250+ industries, placing it below the top-performing half.
Recent analyst estimate changes have remained unchanged over the last 30 days with a current Zacks Rank of #3 (Hold), which does not reflect the strong buy ratings (#1) that historically drive outsized returns.
The stock's relative underperformance persists in a market where technology-centric Nasdaq increased by 0.83%, suggesting potential investor hesitation or specific sector headwinds for Axon.
Shares of Axon Enterprise (NASDAQ: AXON) rebounded significantly today after plunging 10% yesterday, with the stock eventually gaining more than 10.7% before settling at a 4.6% increase as of 2:04 p.m. ET. The previous day's sharp decline was not attributed to any specific fundamental issue but may have been influenced by events surrounding Axon Week annual conference and a legal dispute regarding the company's new planned headquarters, which is set to begin court hearings on Friday. Despite the volatility, analysts attending the conference delivered supportive notes, suggesting that yesterday's sell-off stemmed from non-fundamental factors rather than underlying business deterioration.
Wall Street analysis reflects this optimism, with major firms encouraging investors to consider buying Axon on its recent weakness. TD Cowen lowered its price target from $950 to $825 but maintained a buy rating, citing a "very bullish" customer panel at the conference and noting that Morgan Stanley and Goldman Sachs issued similar assessments urging investment. The broader market context also played a role in the recovery, with gains attributed partly to the recent ceasefire in Iran, which lifted stocks across the board. Currently, Axon shares have pulled back from their early morning highs but remain elevated compared to previous levels.
From a valuation perspective, Axon appears attractive as its price-to-sales ratio has fallen to close to 10, marking one of the cheapest valuations since 2023 while business growth prospects continue to look strong. The company, known for manufacturing TASER electrical weapons, body cameras, and related software, is expected to see more news emerge as Axon Week concludes this Friday. While some investors might consider these positive developments compelling reasons to purchase, others note that Axon was not included in a recent list of top 10 stocks recommended by The Motley Fool Stock Advisor team, which historically has achieved substantial average returns compared to the S&P 500.
The article concludes with standard financial disclosure notes indicating that Jeremy Bowman holds positions in Axon Enterprise and that The Motley Fool recommends the stock, while also highlighting the publication's historical track record through specific past recommendations like Netflix and Nvidia. Readers are directed to explore additional resources regarding Stock Advisor's latest top 10 list available with a subscription, emphasizing the platform's community-focused approach for individual investors.
๐ Axon shares fell 10% amid conference and legal concerns, then rebounded 4.6%.
๐ฐ Valuation at P/S ratio of ~10x, lowest since 2023.
โ Major banks maintain buy ratings despite recent decline.
โ ๏ธ Some analysts exclude Axon due to growth or better alternatives.
๐ Court hearing on headquarters dispute scheduled for Friday.
๐ Axon shares fell 10% yesterday for unclear reasons, potentially linked to its annual Axon Week conference or legal disputes over a new headquarters.
๐ Axon Enterprise manufactures TASER weapons, body cameras, and related software solutions for law enforcement.
๐ Today's trading session saw the stock bounce back, rising up to 10.7% in response to broad market gains from an Iran ceasefire.
โ๏ธ Three Wall Street analysts issued bullish notes today, urging investors to buy into the weakness despite the recent sell-off.
๐ผ TD Cowen lowered its price target from $950 to $825 but maintained its "buy" rating, citing a positive customer panel at Axon Week.
๐ข Morgan Stanley and Goldman Sachs echoed this sentiment, suggesting the previous decline was driven by non-fundamental factors.
๐ Investors should monitor ongoing updates from Axon Week until Friday and a court hearing regarding the headquarters dispute starting Friday.
๐ฐ The company's price-to-sales ratio has dropped to nearly 10, reflecting valuation levels as low as they have been since 2023.
๐ Despite the bounce, some analysts believe growth prospects remain strong even after yesterday's temporary market downturn.
โ ๏ธ Not all analyst coverage is positive; The Motley Fool Stock Advisor team recently excluded Axon Enterprise from their top 10 stock picks.
๐ Stock Advisor notes a total average return of 928% compared to 186% for the S&P 500, highlighting its long-term performance strategy.
๐ธ As of 2:04 p.m. ET, Axon stock settled with gains of 4.6%, giving back some of its early morning rally momentum.
๐ The article highlights a divergence in analyst views, with major banks favoring the stock while other firms see better alternatives.
๐ The legal dispute over the planned headquarters will have its first court hearing on Friday, adding another factor to watch.
Bullish Signals
Axon stock rose 10.7% today after yesterday's decline.
Three analysts issued bullish notes following Axon's conference.
TD Cowen kept a buy rating with very bullish customers.
Axon price-to-sales ratio nears 10, lowest since 2023.
Morgan Stanley and Goldman Sachs urge buying on weakness.
Fool Stock Advisor maintains Axon positions and recommends it.
Risk Factors
Stock hit 18-month low after unexplained 10% drop.
New HQ faces legal dispute with Friday court hearings.
TD Cowen cut price target from $950 to $825.
Excluded from Motley Fool's 10 best stocks list.
Bullish Signals
Axon stock jumped 10.7% today, demonstrating resilience after yesterday's decline.
At least three Wall Street analysts issued bullish notes on Axon following its annual conference.
TD Cowen maintained a buy rating and stated the customer panel at Axon Week was 'very bullish'.
The company's price-to-sales ratio has fallen to close to 10, as cheap as it's been since 2023.
Analysts from Morgan Stanley and Goldman Sachs gave similar assessments, urging investors to buy on weakness.
The Motley Fool Stock Advisor analyst team maintains positions in Axon Enterprise and recommends the stock.
Risk Factors
Axon stock hit an 18-month low yesterday following an unexplained 10% decline, raising concerns about investor sentiment.
A new planned headquarters faces a legal dispute with court hearings scheduled for Friday, creating potential regulatory and financial risks.
TD Cowen lowered its price target from $950 to $825 in response to the recent sell-off, indicating some analysts see near-term downside.
Axon Enterprise was excluded from The Motley Fool Stock Advisor's list of 10 best stocks to buy now despite positive analyst notes from major firms like Morgan Stanley and Goldman Sachs.
Axon Enterprise (NASDAQ: AXON) experienced a significant stock decline on Tuesday, closing down 9.7% and dropping more than 12% during the trading session, marking a new 18-month low without an immediately obvious catalyst. The sell-off coincided with two primary potential drivers identified by the company's situation: first, escalating legal and political challenges regarding its proposed $1.3 billion campus in North Scottsdale, Arizona, and second, mixed sentiment surrounding its annual Axon Week industry conference that began on Monday. The Scottsdale project, originally approved by the city council in November to house its global headquarters, manufacturing facilities, 1,200 residential units, a hotel, and commercial space on 76 acres, faced a referendum threat from a labor union that forced a ballot vote in January. Although Arizona later blocked the referendum, new aggressive lawsuits have now been filed by opponents specifically targeting the residential apartment component of the development, with oral arguments expected to begin on Friday, potentially stalling Axon's growth ambitions if unsuccessful in court.
Beyond the headquarters controversy, Axon Week offered a backdrop of mixed signals for investors, despite announcements of promising new AI-driven products such as Axon Vision, an AI-based tool for real-time video recognition; Axon Assistant, an add-on feature for body cameras; and Axon 911, a cloud-based infrastructure solution for 911 dispatch centers built on the acquisition of Prepared and Carbyne. The stock's sharp pullback also contributed to a broader correction for Axon in 2026, following a strong earnings report in February but amidst a wider sell-off in software stocks. Consequently, Axon's price-to-sales ratio has fallen below 10 for the first time since 2023, down from near 30 at its peak in 2025, which analysts suggest makes the current valuation appear more reasonable compared to previous highs despite the company continuing to grow rapidly through acquisitions and AI investments.
While the hardware division of Axon is credited with providing a buffer against the AI disruption currently affecting enterprise software stocks, investors are advised to monitor the outcomes of both the legal battles over the Scottsdale project and the remaining developments from Axon Week before making investment decisions. The article concludes that despite these challenges, the stock may represent an attractive buying opportunity at current levels, though this analysis is accompanied by a promotional note regarding The Motley Fool Stock Advisor's top 10 list, which excluded Axon Enterprise while highlighting its own historical returns and recommending that investors consider alternative recommendations available through their subscription service.
๐ Stock fell 9.7% amid legal disputes over Arizona campus project halted by union.
โ๏ธ Lawsuits may block residential units, threatening growth and expansion plans if lost in court.
๐ค Company showcased three new AI tools, including Axon Vision and cloud infrastructure for 911 centers.
๐ Axon Enterprise (NASDAQ: AXON) stock dropped 9.7% on Tuesday, trading near an 18-month low despite no major earnings news.
๐ข A potential catalyst for the decline is legal controversy surrounding Axon's $1.3 billion campus development in North Scottsdale, Arizona.
โ๏ธ Lawsuits were filed to block the project's residential units, with oral arguments expected to begin this Friday regarding the project's future.
๐ Axon had previously halted construction on its headquarters after a labor union forced a referendum on the development, which was later blocked by Arizona.
โ A loss in these upcoming court proceedings could significantly hinder Axon's growth ambitions and expansion plans.
๐ค During Axon Week industry conference, the company announced three new AI tools including Axon Vision for live video recognition.
๐ New products include Axon Assistant for body cameras and Axon 911 offering cloud infrastructure for 911 dispatch centers.
๐ The stock pullback adds to a rough 2026 following a broader sell-off in software stocks despite strong earnings earlier this year.
๐ฐ Axon's price-to-sales ratio has fallen below 10 for the first time since 2023, dropping from a peak of near 30 in 2025.
๐ The company continues to grow rapidly through acquisitions and investments in AI while consolidating its law enforcement technology leadership.
๐ก๏ธ Axon's hardware business is noted as protecting against current disruption threats menacing enterprise software stocks generally.
๐ก Investors are advised to monitor ongoing legal updates and further news from the industry conference before making decisions.
๐ Analysts suggest the current valuation looks more reasonable than six months ago, presenting a potential buying opportunity for some.
๐ซ The Motley Fool Stock Advisor team explicitly did not include Axon in their latest list of 10 best stocks to buy now.
๐น The advisory article promotes their historical performance on top stock picks, citing Netflix and Nvidia as examples of past winners.
โ ๏ธ Jeremy Bowman holds a position in Axon Enterprise, creating a potential conflict of interest regarding the publication's recommendation.
Bullish Signals
Axon executes well despite market volatility with strong fundamentals.
Rapid growth continues through acquisitions and AI investments.
Three new AI tools launched: Axon Vision, Assistant, and 911.
Hardware business protects against enterprise software disruption.
Price-to-sales ratio falls below 10 from 2025 peak of near 30.
North Scottsdale campus remains key for growth and talent.
Risk Factors
Stock plunged 12% without negative catalysts, hitting 18-month low.
Union forced $1.3B campus referendum, halting project and costing new search.
Two lawsuits target apartments; court arguments could halt growth if lost.
Price-to-sales ratio fell below 10 from peak of 30 in 2025.
Stock caught in software sell-off despite strong February earnings report.
No positive news from Axon Week, suggesting possible undisclosed negatives.
Bullish Signals
Axon Enterprise is executing well despite recent market volatility, with its business fundamentals remaining strong.
The company continues to grow rapidly and is consolidating its leadership in law enforcement technology through acquisitions and investments in AI.
Recent product announcements include three new AI tools: Axon Vision for real-time video recognition, Axon Assistant for body cameras, and Axon 911 for cloud-based dispatch infrastructure.
Axon's hardware business protects it from the AI disruption threat that is currently affecting enterprise software stocks.
The stock's price-to-sales ratio has fallen to below 10 for the first time since 2023, down from near 30 at its peak in 2025, making the valuation look more reasonable.
Management continues to see the North Scottsdale campus as key for continued growth and attracting top-tier talent, even amid legal challenges.
Risk Factors
Axon Enterprise stock plunged nearly 12% during the session, hitting an 18-month low without any obvious negative news catalysts.
A labor union successfully collected enough signatures to force a ballot referendum on Axon's new $1.3 billion campus in North Scottsdale, Arizona, leading the company to halt the headquarters project and begin a costly nationwide search for a new location.
Opposition groups have filed two aggressive lawsuits specifically targeting the residential apartments component of the development, with oral arguments expected to begin this Friday that could halt growth ambitions if lost in court.
Axon's stock price-to-sales ratio has fallen below 10 for the first time since 2023, down from a peak of near 30 at its height in 2025, indicating significant valuation compression despite strong earnings.
The company is getting swept up in a broader sell-off in software stocks that persists despite a strong earnings report delivered in February.
There was no clear positive news from Axon Week's industry conference to counter the selling pressure, though analysts may have heard undisclosed negative information.
Shares of self-defense technology company Axon (NASDAQ: AXON) declined by 10.2% during an afternoon trading session on Tuesday, April 7, driven by emerging legal uncertainties and downward revisions to price targets from major Wall Street analysts. The volatility stems primarily from a court hearing concerning lawsuits challenging the company's planned $1.3 billion headquarters project in Arizona, which has created significant ambiguity regarding future capital expenditures and expansion plans. Concurrently, prominent financial institutions such as Bank of America and RBC Capital reduced their stock price targets, further dampening investor sentiment despite Axon maintaining its position as a high-profile name in the self-defense sector.
Historically, Axon shares have demonstrated extreme volatility, with 21 separate movements exceeding 5% over the past year, though the current decline was considered a significant outlier by analysts observing the market reaction. This downturn contrasts sharply with earlier positive momentum; roughly one month prior, the stock surged 23.8% following the announcement of robust fourth-quarter financial results that exceeded Wall Street expectations. During that quarter, Axon reported revenue of $796.7 million, representing a 38.5% year-over-year increase, while adjusted earnings per share reached $2.15 against a consensus estimate of $1.60, accompanied by an upbeat forward guidance outlook that previously drove strong investor confidence.
Following the recent market correction, Axon shares have declined 33.8% since the start of the current year and are trading at approximately $372.85 per share, which is 57.2% below its 52-week high of $870.97 recorded in August 2025. Despite the recent price action, the company retains long-term value for investors; those who purchased $1,000 worth of Axon stock five years ago would now see their investment valued at approximately $2,532. Market analysts caution that large price drops often reflect market overreactions to news and could present buying opportunities for high-quality stocks, though the specific legal challenges regarding the Arizona headquarters remain a key factor in determining future risk exposure and valuation.
๐ Axon shares fell 10.2% on new legal risks and analyst downgrades.
โ Court hearing over Arizona HQ project added uncertainty about expansion spending.
๐ฐ Quarterly revenue hit $796.7M, beating forecasts with EPS of $2.15.
๐ Axon shares fell 10.2% in the afternoon trading session on Tuesday, April 7, following new legal risks and analyst price target cuts.
โ๏ธ A court hearing regarding lawsuits challenging the $1.3 billion headquarters project in Arizona created uncertainty about future spending and expansion.
๐ Bank of America and RBC Capital reduced their price targets for Axon stock alongside other major firms.
๐ Axon's stock has been volatile, recording 21 moves greater than 5% over the last year, with today's drop being a rare significant impact event.
๐ The largest recent positive move occurred about a month ago when shares gained 23.8% on strong fourth-quarter financial results.
๐ฐ Axon reported quarterly revenue of $796.7 million, representing a 38.5% year-over-year increase that surpassed analyst forecasts.
๐ต Adjusted earnings per share reached $2.15, significantly beating the consensus estimate of $1.60 during the strong fiscal quarter.
๐ Axon stock is currently down 33.8% year-to-date, trading at $372.85, which is 57.2% below its 52-week high of $870.97.
๐ฐ๏ธ Despite the recent decline, shares purchased five years ago would now be worth $2,532 per share on a $1,000 initial investment.
Bullish Signals
Axon reported strong fourth-quarter results beating Wall Street expectations.
Revenue reached $796.7 million, a 38.5% increase year-over-year.
Adjusted earnings per share hit $2.15 versus $1.60 estimate.
Positive sentiment drove stock gains after confident guidance release.
Shares rose 23.8% in one month from strong performance.
Current investment value reached $2,532 for initial $1,000 purchase.
Stock trades below 52-week high of $870.97 despite YTD decline.
Risk Factors
Shares fell 10.2% amid legal risks and analyst cuts.
Court hearing creates uncertainty on $1.3B Arizona project.
Major firms lower price targets showing reduced confidence.
Stock down 33.8% YTD and trades 57.2% below 52-week high.
Significant volatility signals major negative market perception.
Bullish Signals
Axon reported strong fourth-quarter financial results that beat Wall Street's expectations, with revenue reaching $796.7 million.
Revenue marked a 38.5% increase compared to the same period in the previous year and surpassed analysts' forecasts.
Adjusted earnings per share came in at $2.15, significantly higher than the consensus estimate of $1.60.
The strong performance and confident guidance drove positive investor sentiment just one month ago when the stock gained 23.8%.
Investors who bought $1,000 worth of Axon's shares 5 years ago would now be looking at an investment worth $2,532.
Despite a year-to-date decline, Axon trades below its 52-week high of $870.97 from August 2025.
Risk Factors
Shares of Axon (AXON) fell 10.2% in the afternoon session following new legal risks and multiple price target cuts from Wall Street analysts.
A court hearing regarding lawsuits challenging Axon's $1.3 billion headquarters project in Arizona has created uncertainty about the company's future spending and expansion plans.
Major firms including Bank of America and RBC Capital have lowered their price targets for the stock, indicating reduced analyst confidence.
The stock is down 33.8% since the beginning of the year and trades 57.2% below its 52-week high of $870.97 from August 2025.
Axon has experienced significant volatility with 21 price moves greater than 5% over the last year, though recent drops are unusual and signal a major negative market perception shift.
Axon Enterprise, Inc. (AXON) shares have declined approximately 11.5% since its fourth-quarter 2025 earnings report released over a month ago, underperforming the broader S&P 500 despite reporting strong financial results that beat consensus estimates. In Q4 2025, the company delivered adjusted earnings of $2.15 per share versus an expectation of $1.67, and revenues reached $797 million compared to a forecast of $753.6 million. These top-line results were driven by robust demand for its TASER 10 devices, Axon Body 4 body-worn cameras, counter-drone equipment, and increasing adoption of premium software solutions across both its newly aligned business segments: Connected Devices and Software & Services.
The broader fiscal year 2025 saw net revenues increase by 33.5% to $2.78 billion, with adjusted earnings rising 15.3% to $6.85 per share. However, the company faced margin pressure as its adjusted gross margin decreased to 61.1% from the prior year, primarily due to global tariff-related impacts and a shift toward higher-margin Platform Solutions products within the Connected Devices segment. Cash flow metrics showed a significant reduction in operating cash generation for 2025 at $211.3 million compared to $408.3 million in the previous year, while adjusted free cash flow dropped to $85.6 million from $344.3 million, though the company holds substantial cash reserves of $1.2 billion as of the end of Q4 2025.
Looking ahead, management expects revenues for fiscal 2026 to grow between 27% and 30% year over year with an adjusted EBITDA margin target of 25.5%. The company plans to reinvest between $185 million and $215 million in capital expenditures for capacity expansion, facility build-outs, and research and development, anticipating stock-based compensation expenses of roughly $230 million. Long-term guidance includes a projection to reach $6 billion in annual revenues by 2028 with an adjusted EBITDA margin of approximately 28%, alongside a goal to limit dilution from equity compensation to less than 2.5% annually.
Following the earnings release, analyst sentiment has shifted negatively, leading to downward revisions in consensus estimates that have contributed to the stock's current Zacks Rank #3 (Hold) rating and an aggregate VGM Score of D. While the stock holds an A-grade Momentum Score based on recent technical performance, it carries a C-grade Growth Score and an F-grade Value Score, placing it in the bottom 20% for value-based investment strategies. The article concludes with an expectation of in-line returns over the coming months and notes that the stock operates within the Zacks Aerospace - Defense Equipment industry.
๐ฐ Full-year earnings rose 15.3%, but operating cash flow fell significantly.
โ Gross margins declined due to tariffs and a shift to lower-margin products.
๐ฎ Management forecasts $6B annual revenue by 2028 with 27-30% growth.
๐ Zacks assigns a "Hold" rating after analyst estimates were sharply revised down.
๐ Shares of Axon Enterprise (AXON) have declined approximately 11.5% over the last month, significantly underperforming the S&P 500.
๐ฐ The company reported Q4 2025 adjusted earnings of $2.15 per share, exceeding the consensus estimate of $1.67 and rising 3.4% year-over-year.
๐ฆ Total revenues reached $797 million in Q4 2025, surpassing estimates by beating expectations with a 39% year-over-year increase.
๐ณ Full-year 2025 net revenue totaled $2.78 billion, marking a 33.5% increase, while adjusted earnings per share reached $6.85 (up 15.3%).
๐ง Revenue growth was driven by strong demand for key products including the TASER 10, Axon Body 4, and counter-drone equipment.
๐ Analysts are now split between two business segments: Connected Devices ($454.2M revenue) and Software & Services ($342.5M revenue).
โ ๏ธ Adjusted gross margins declined in both segments for Q4 2025 due to tariff impacts, a higher mix of lower-margin products, and increased operating expenses.
๐ธ Operating cash flow generated in 2025 was $211.3 million, down from $408.3 million the prior year, with adjusted free cash flow dropping to $85.6 million.
๐ Management forecasts Q1-Q4 2026 revenue growth of 27-30% and anticipates achieving annual revenues of $6 billion by 2028.
โ๏ธ Planned capital expenditures for 2026 range between $185 million and $215 million to fund R&D, capacity expansion, and new product development.
๐ Recent investor sentiment has led analysts to revise downward on fresh estimates, shifting the consensus estimate by -76.6%.
๐ Axon currently holds an average Growth Score of C, a Momentum Score of A, but a Value grade of F (bottom 20% quintile).
๐ Based on these metrics, Axon has been assigned a Zacks Rank #3 (Hold) with expectations for in-line returns in the coming months.
Bullish Signals
Beat Q4 EPS estimate at $2.15 vs $1.67.
Revenues grew 39% YoY on strong TASER and software demand.
Total 2025 revenues rose 33.5% to $2.78 billion.
Software segment revenue up nearly 40% from user growth.
Projects 2026 revenue growth of 27-30% with 25.5% EBITDA.
Aims for $6B annual revenue by 2028 at 28% margin.
Plans to cap stock-based dilution under 2.5% annually.
Risk Factors
Shares dropped 11.5% underperforming S&P 500.
Adjusted free cash flow fell to $85.6M from $344.3M.
Operating expenses rose 41.1% while net cash flow declined 48.2%.
Stock graded F in bottom 20% investment quintile.
Analyst estimates shifted down by -76.6%.
Bullish Signals
Axon reported fourth-quarter 2025 adjusted earnings of $2.15 per share, significantly beating the Zacks Consensus Estimate of $1.67.
Total revenues reached $797 million, surpassing the consensus estimate of $753.6 million and growing 39% year over year driven by strong demand for TASER 10, Axon Body 4, and counter-drone equipment.
In 2025, the company reported net revenues of $2.78 billion, an increase of 33.5% year over year.
For the Software & Services segment, revenues rose 39.8% year over year to $342.5 million due to growing adoption of premium software offerings and an increase in the aggregate number of users.
Axon expects revenues to grow between 27-30% year over year in 2026 with an adjusted EBITDA margin projected at 25.5%.
The company anticipates achieving annual revenues of $6 billion by 2028, with an adjusted EBITDA margin expected to be about 28%.
Management plans to limit annual dilution from stock-based compensation to less than 2.5%, ensuring a controlled capital structure for future growth.
Risk Factors
Shares have dropped 11.5% since the last earnings report, underperforming the S&P 500.
Adjusted free cash flow significantly decreased to $85.6 million in 2025 from $344.3 million in the prior-year period.
Operating expenses climbed 41.1% year over year, while net operating cash flow declined 48.2% to $211.3 million.
The stock received a grade of F on the value side and sits in the bottom 20% quintile for the investment strategy.
Analyst consensus estimates have shifted down by -76.6%, with investors witnessing a downward trend in fresh estimates.
The Zacks Rank is #3 (Hold), which typically indicates an expectation of only in-line returns rather than significant outperformance.
Despite strong revenue growth, the adjusted gross margin decreased to 61.1% from 63.2%, attributed to global tariff impacts and higher product mix.
Axon Enterprise and Teledyne Technologies are two prominent competitors in the aerospace and defense sector, specializing in public security and digital imaging solutions. Axon has experienced significant growth driven by its Connected Devices segment, which saw revenues increase 29.1% year over year in 2025. This expansion is fueled by strong demand for products such as the Axon Body 4 body-worn camera, the TASER 10 handle, and counter-drone equipment, with revenues from TASER growing 21.8% and Personal Sensors surging 25.3% in 2025. Additionally, its Software & Services segment recorded a 39.6% revenue increase in 2025, supported by digital evidence management and AI-powered command-and-control platforms like Dedrone.
Despite this revenue growth, Axon faces margin pressures due to escalating costs. In the first quarter of 2025, its cost of sales rose 18.2% while SG&A expenses jumped 48%, pushing total operating expenses to $374.5 million, largely due to business integration activities and higher wages. Teledyne, conversely, is benefiting from rising defense spending in Europe and a recovering commercial aviation market, with sales from its Aerospace and Defense Electronics segment up 40.4% year over year in the fourth quarter of 2025. The company has also bolstered its portfolio through acquisitions, including DD-Scientific Holdings in January 2026 and TransponderTech from Saab AB in October 2025, though it contends with supply-chain challenges such as increased lead times and component cost inflation.
Recent market performance shows divergence between the two stocks, with Axon shares declining 28.8% over the past six months while Teledyne stock gained 10.2%. Analyst forecasts indicate stronger projected growth for Axon, with Zacks Consensus Estimates predicting a 28.3% increase in 2026 sales and 18.5% growth in earnings per share compared to Teledyneโs expected 4.1% sales growth and 8.5% EPS increase for the same period. Valuation-wise, Teledyne trades at a forward 12-month price-to-earnings ratio of 25.68X, while Axon is currently trading at a lower multiple than implied by its projected earnings acceleration.
๐ Axon's Connected Devices and Software segments grew significantly in 2025 driven by new hardware and subscriptions.
๐ป Teledyne outperformed with strong defense demand, acquisitions, and a 40.4% rise in its Aerospace segment.
โ Both companies face operational headwinds like supply chain issues and rising expenses affecting cash flow.
๐ Axon shares dropped sharply compared to Teledyne's gains despite similar long-term sales growth forecasts.
๐ Axon Enterpriseโs Connected Devices segment grew 29.1% year-over-year in 2025, driven by VR training, TASER 10, and counter-drone equipment.
๐ท The launch of the Axon Body 4 body-worn camera boosted demand through enhanced bi-directional communications and POV features.
โก TASER revenues increased 21.8% in 2025 led by the TASER 10 model, while Personal Sensors revenue rose 25.3%.
๐ Platform Solutions revenues surged 72.5% in 2025 due to counter-drone, virtual reality, and fleet solutions adoption.
๐ป Software & Services segment grew 39.6% in 2025, fueled by digital evidence management and premium subscription plans.
๐ค Axon is strengthening its position in counter-drone defense with AI-powered command-and-control platforms via Dedrone offerings.
โ ๏ธ Axon faced rising costs and expenses in Q1 2025, including 48% higher SG&A expenses due to integration activities and higher compensation.
๐ก Teledyne benefits from strong European defense demand driven by regional spending increases and favorable U.S. defense policies.
โ Commercial air travel recovery supports Teledyneโs growth, with IATA predicting a 4.9% rise in passenger kilometers for 2026.
๐ง Teledyneโs Aerospace and Defense Electronics segment rose 40.4% year-over-year in Q4 2025 due to acquisitions and organic growth.
๐ค Teledyne acquired DD-Scientific Holdings in January 2026 to expand sensing and electronics capabilities.
โ Teledyne also acquired TransponderTech from Saab AB in October 2025 to add connected maritime products to its portfolio.
โ ๏ธ Supply chain challenges for Teledyne include increased lead times, parts cost inflation, and potential sluggish aircraft deliveries impacting cash flow.
๐ Axon shares lost 28.8% over the past six months compared to a 10.2% gain for Teledyne during the same period.
๐ Analyst estimates project Axonโs 2026 sales growth of 28.3% and EPS growth of 18.5%.
๐ Teledyne is forecast to grow 2026 sales by 4.1% with an estimated 8.5% EPS increase for the same period.
๐ฐ Teledyne trades at a forward 12-month P/E ratio of 25.68X, presenting a potentially more attractive valuation than Axon.
Bullish Signals
Segmental revenues for Axon increased 29.1% in 2025.
TASER and Personal Sensors revenues rose 21.8% and 25.3% respectively in 2025.
Platform Solutions product line revenues soared 72.5% in 2025.
Software & Services segment revenues increased 39.6% in 2025.
Axon acquired DD-Scientific to expand sensing and electronics portfolio in Jan 2026.
Teledyne aerospace sales rose 40.4% in Q4 2025 driven by acquisitions.
Zacks EPS growth estimate for AXON is 18.5% for 2026.
Teledyne trades at attractive forward P/E of 25.68X.
Commercial air travel demand expected to rise 4.9% in 2026.
Bullish Signals
Segmental revenues for Axon increased 29.1% year over year in 2025, driven by strong demand for virtual reality training, TASER 10 handles, and counter-drone equipment.
The introduction of the next-generation Axon Body 4 camera in 2023 is generating significant demand, boosting growth in both Connected Devices and Personal Sensors segments.
TASER product line revenues increased 21.8% year over year in 2025, while Personal Sensors surged 25.3%, primarily led by the Axon Body 4 camera.
Platform Solutions product line revenues soared 72.5% in 2025, supported by counter-drone, virtual reality, and fleet offerings.
The Software & Services segment showed continued momentum with revenues increasing 39.6% in 2025 following a 33.4% jump in 2024.
Adoption of premium subscription plans continues to rise as more customers recognize the value of enhanced capabilities.
Teledyne is experiencing strong demand from the defense sector, particularly in Europe, driven by rising regional defense spending and favorable macroeconomic conditions.
Commercial air travel rebound is serving as a key growth driver for Teledyne, with IATA expecting demand for air travel to rise 4.9% in 2026.
Teledyne's Aerospace and Defense Electronics segment sales rose 40.4% year over year in the fourth quarter of 2025, fueled by acquisitions and organic growth.
Axon recently acquired DD-Scientific Holdings Limited in January 2026 to expand its differentiated sensing and electronics portfolio.
Teledyne acquired TransponderTech business from Saab AB in October 2025 to add connected commercial maritime products to its portfolio.
The Zacks Consensus Estimate for AXON implies year-over-year EPS growth of 18.5% in 2026, with EPS estimates increasing over the past 60 days.
Teledyne's EPS estimates have been trending northward for both 2026 and 2027 over the past 60 days.
Teledyne is trading at a forward 12-month price-to-earnings ratio of 25.68X, presenting an attractive valuation compared to Axon.
Risk Factors
Escalating costs and expenses pose a significant threat to Axon's margins and profitability, with SG&A expenses surging 48% and total operating expenses climbing 54.7% year over year in Q1 2025.
High operational burdens from business integration activities, increased headcount, higher wages, and stock-based compensation are driving up costs rapidly.
The Zacks Consensus Estimate for Axon's 2026 EPS growth of 18.5% is significantly trailing Teledyne's projected 8.5% EPS growth in the same period, indicating weaker future earnings expectations.
Axon shares have lost 28.8% over the past six months, while Teledyne has gained 10.2%, reflecting negative market sentiment and significant downside pressure on Axon stock.
Teledyne faces supply-chain challenges including increased lead times and cost inflation for parts, which may lead to slower aircraft deliveries and result in slow cash flow for component manufacturers like itself.
The article highlights two technology stocks, The Trade Desk (TTD) and Axon Enterprise (AXON), as potential wealth-building opportunities for long-term investors focused on competitive positioning within the tech sector. The author argues that both companies are well-positioned in fast-growing marketsโdigital advertising for TTD and public safety with AI-driven tools for AXONโand are currently trading at discounts relative to their historical highs or future potential. The piece notes that while digital ad spending is expected to exceed $950 billion by 2026, The Trade Desk has shown strong retention rates exceeding 95% over a decade and grew gross spending by 18% in the prior year despite some slowing growth due to weaknesses in consumer goods and auto sectors.
Axon Enterprise is presented as having successfully evolved from selling hardware like Taser devices into a comprehensive software platform that integrates data from body cameras, drones, and cloud services. The company reported a 39% surge in total revenue to $797 million in the fourth quarter, with AI-powered product bookings nearly tripling to over $1 billion last year. Although concerns exist about AI disrupting its cloud offerings, the author emphasizes Axon's data moat derived from real-world collections used to train specialized AI products. Management has provided specific guidance expecting annual revenue to reach $6 billion by 2028 with adjusted operating margins of 28%, while future contracted bookings stand above $14 billion.
The analysis suggests that patient investors could find value in these stocks despite current market sentiment, noting The Trade Desk trades at just 11 times this year's earnings and Axon is trading below its previous peak. However, the article concludes by directing readers to a promotional pitch for "Stock Advisor," a subscription service recommended by John Ballard of The Motley Fool, which identifies ten other stocks believed to outperform the market significantly, with TTD notably absent from that specific list despite being featured in this bullish analysis.
๐ TTD targets a $950B digital ad market with strong 95% customer retention rates.
๐ TTD trades at low multiples despite slowing growth in key consumer sectors.
๐ค Axon transforms into an AI platform, driving Q4 revenue up 39%.
๐พ Axon leverages a massive data moat to unlock $6B revenue by 2028.
๐ The digital advertising market is projected to exceed $950 billion by 2026, creating a massive opportunity for The Trade Desk (TTD).
๐ผ The Trade Desk operates on a customer-first ad-buying platform that retains over 95% of its customers annually.
๐ Despite strong fundamentals, TTD stock is trading at just 11 times this year's earnings estimate as it moves well off its highs.
๐ Slowing growth in key sectors like consumer goods and auto has weighed on the stock, but management expects a tailwind from improving economic conditions.
๐ค Axon Enterprise (AXON) is evolving from a Taser manufacturer into an AI-driven law enforcement platform combining hardware and cloud software.
๐ฑ In Q4, Axon's total revenue surged 39% year-over-year to $797 million, with software revenue growing by 40%.
๐พ Axon's "data moat" comes from its ability to collect real-world data at scale to train AI products that solve specific agency problems.
๐ Bookings for Axon's AI-powered products nearly tripled last year to surpass $1 billion, signaling the start of a new growth phase.
๐ Management projects Axon's annual revenue will reach $6 billion by 2028 with an adjusted operating margin of 28%.
๐ฎ Analysts forecast Axon's earnings to grow at an annualized rate of 38% in the coming years despite current valuation concerns.
๐ Axon plans to expand its market reach into enterprise, corrections, federal, and international sectors.
โ๏ธ The stock is trading below previous peaks amid fears that AI could disrupt its cloud software, which analysts suggest may overlook Axon's competitive advantages.
๐ฐ Investors are looking for long-term growth in tech stocks with substantial potential as the sector historically delivers excellent returns.
๐ The Motley Fool Stock Advisor team has highlighted these two stocks as key players in their fast-growing respective markets.
โ ๏ธ TTD is currently capturing a fraction of its $1 trillion addressable market, leaving ample room for future wealth-building returns.
Bullish Signals
Axon combines hardware and AI tools to drive strong revenue growth.
Axon Q4 revenue surged 39% YoY to $797 million.
Axon annual recurring revenue reached $1.3 billion, up 35%.
Axon AI product bookings nearly tripled to over $1 billion.
Axon future contracted bookings top $14 billion for long-term growth.
Risk Factors
Slowing growth hurt TTD stock due to consumer goods and auto weakness.
Generative AI threatens Axon's core software offering and competitive edge.
TTD trades at low 11x earnings despite double-digit growth forecasts.
High 64x multiple for AXON may not justify $6B 2028 revenue targets.
Analysts excluded TTD from top picks, signaling lack of immediate buy ratings.
Bullish Signals
Axon is building a powerful growth engine with AI-driven law enforcement tools combining hardware and cloud services, generating strong revenue.
In the fourth quarter, Axon's total revenue surged 39% year-over-year to $797 million, while software revenue specifically grew 40%.
Axon's annual recurring revenue reached $1.3 billion, growing 35%, supported by high-margin software and services that expand hardware customer relationships.
Bookings from Axon's AI-powered products nearly tripled last year to over $1 billion, indicating rapid adoption of its new technology stack.
The company has future contracted bookings topping $14 billion, providing clear visibility into long-term growth potential.
Management forecasts annual revenue reaching $6 billion by 2028 with adjusted operating margins expanding to 28%.
Analysts expect Axon's earnings to grow at an annualized rate of 38% in the coming years, fueling excellent long-term returns.
The digital advertising market is expected to exceed $950 billion in 2026, providing a massive opportunity for The Trade Desk to capture significant market share.
The Trade Desk retains more than 95% of its customers over the last 12 years due to its customer-centric ad-buying experience that prioritizes client needs.
Despite trading at just 11 times this year's earnings estimate, analysts forecast The Trade Desk to grow earnings at double-digit rates going forward.
Risk Factors
Slowing growth has negatively impacted The Trade Desk's stock price over the past year, attributed to weakness in consumer goods and auto sectors which represent 25% of its business.
Axon Enterprise faces significant headwinds from concerns that generative AI could disrupt its core cloud software offering, potentially eroding its competitive advantage.
The Trade Desk trades at a relatively low valuation of 11 times this year's earnings estimate despite double-digit earnings growth forecasts, indicating potential lack of market confidence compared to historical highs.
Axon Enterprise commands a high forward earnings multiple of 64, which may not be fully justified if its long-term revenue growth projections of $6 billion by 2028 are overstated or if margins fail to reach the anticipated 28%.
The Motley Fool Stock Advisor analyst team recently identified the top 10 best stocks for investors and notably excluded The Trade Desk from their list, suggesting a lack of immediate buy recommendation from influential analysts.
Axon Enterprise, the dominant player in law enforcement technology, is highlighted as an AI investment opportunity despite recent market volatility. The company has grown its stock by 2,570% over the last decade but has dropped more than 40% from its peak due to broader fears regarding AI disruption in software sectors. Financial performance remains robust, with the company reporting 33% revenue growth for 2025, bringing total annual revenue to $2.8 billion. The fourth quarter specifically saw a 39% jump in the top line to $797 million and adjusted EBITDA of $124.5 million.
The article emphasizes Axon's technological differentiation through its new AI innovations introduced in 2024, primarily "Draft One," a generative AI tool that writes initial police reports based on camera footage, and the voice-activated "Axon Assistant." These tools are designed to save officers time while enhancing the utility of their core hardware. Looking ahead, the company plans to unveil further innovations at its Axon Week conference in May and projects revenue reaching $8 billion by 2028, which would nearly triple current figures from 2025 levels.
While acknowledging the stock may be expensive, the analysis suggests strong growth potential driven by these technological advantages. The piece also notes that The Motley Fool's Stock Advisor service did not currently include Axon Enterprise in its list of top ten stocks for buying, though it references historical performance of similar recommendations like Netflix and Nvidia to illustrate potential returns. Disclosures indicate that Jeremy Bowman holds positions in both Axon and Nvidia, and The Motley Fool has an investment position in these companies.
๐ค Axon dominates law enforcement tech with 33% revenue growth and $2.8B in 2025.
๐ Shares surged 2,570% over a decade but recently dipped 40% amid AI fears.
๐ง New AI tools like Draft One and the Assistant offer real-time translation for officers.
๐ Analysts forecast revenue could triple to $8B by 2028 despite current high valuations.
โญ Axon serves as a critical tech provider relied upon by Nvidia and Intel.
๐ค Axon Enterprise is highlighted as a potential "millionaire-maker" AI stock due to its dominance in law enforcement technology.
๐ The company reported 33% revenue growth in 2025, reaching $2.8 billion, with a 39% jump in Q4 earnings to $797 million.
๐ฐ Axon's shares have surged 2,570% over the last decade but recently dipped over 40% from their peak amid AI sector fears.
๐ง In 2024, Axon launched Draft One, an AI tool that generates police report drafts from camera footage to save officer time.
๐ค The new Axon Assistant is a voice-activated AI companion built into body cameras offering real-time translation and policy answers.
๐ Management plans to unveil further AI innovations at the upcoming Axon Week conference in May.
๐ Analysts forecast Axon's revenue could triple to $8 billion by 2028 if current momentum continues.
โ ๏ธ The stock is considered expensive but offers strong growth potential due to its technological differentiation.
๐ The Motley Fool notes that Axon was excluded from their recent list of top 10 recommended stocks for investors.
โญ Historical examples show that stocks on The Motley Fool's Stock Advisor list have delivered massive returns, such as Netflix and Nvidia.
๐ The Motley Fool's Stock Advisor has an average return of 952% compared to the S&P 500's 191%.
โ๏ธ Jeremy Bowman holds positions in both Axon Enterprise and Nvidia at the time of publication.
๐ข The article identifies Axon as a critical technology provider that both Nvidia and Intel rely upon.
๐น Axon is the clear market leader in law enforcement tech, producing TASERs, cameras, and evidence management software.
๐ค These AI advancements are described as first-of-their-kind developments intended to create a unique competitive moat.
Bullish Signals
AXON dominates law enforcement tech with major advantages.
Revenue surged 39% in Q4 to $797 million.
AI innovations like Draft One and Axon Assistant lead.
First-of-their-kind AI advancements revealed at May conference.
Revenue projected to triple to $8 billion by 2028.
Risk Factors
Stock down 40% amid AI disruption fears.
Omitted from Motley Fool's top 10 list.
Expensive price raises valuation concerns.
Bullish Signals
Axon Enterprise is the clear leader in the law enforcement technology industry with a significant competitive advantage following years of product innovations and acquisitions.
The stock has demonstrated exceptional momentum, posting 33% revenue growth to reach $2.8 billion in 2025 and a 39% increase in Q4 revenue to $797 million.
Axon is pioneering unique AI innovations, including Draft One for generating police report drafts from camera footage and the Axon Assistant voice-activated companion for real-time translation and policy support.
The company plans to announce further first-of-their-kind AI advancements at its upcoming Axon Week conference in May, indicating a strong pipeline of technological differentiation.
Axon expects revenue to triple and reach $8 billion by 2028, presenting significant upside potential for investors despite current stock price concerns.
Risk Factors
The stock is down more than 40% from its recent peak due to broader pressure on software stocks amid fears of AI disruption.
Axon Enterprise was not included in The Motley Fool Stock Advisor's list of the 10 best stocks for investors to buy now, suggesting potential downside relative to their top picks.
The current stock price is described as expensive, raising concerns about valuation and limiting immediate upside potential even if revenue targets are met.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)